TABLE 1.
Age at inoculation (days) | Proportion of mice with clinical scrapie | Incubation period (mean ± SEM) (days) | Proportion of mice with detectable PrPSc in their spleensa
|
||
---|---|---|---|---|---|
70 d.p.i. | Terminal scrapie | Survivors | |||
0-1 | 9/27b | 334 ± 7 | 0/12 | 9/9 | 1/18b |
10 | 28/28 | 308 ± 6 | 11/12 | NT | NA |
14 | 28/28 | 284 ± 6 | 12/12 | NT | NA |
29-46 | 29/29 | 305 ± 5 | 12/12 | NT | NA |
NT, not tested; NA, not applicable.
A total of 18 of 27 mice, referred to as survivors, remained free of clinical signs of scrapie beyond 550 d.p.i.; no TSE-related pathology was detected in their brains.